"Acute Stroke Treatment: A Time for Innovation"

STAIR VI Sponsors

Acorda Therapeutics, Inc.

AmKor Pharma, Inc.

Asubio Pharmaceuticals, Inc.

Balboa Biosciences

Bio-Imaging Technologies, Inc. Biotechnology Value Fund, LP

Biotrofix, Inc.

Boston Scientific

BrainsGate Ltd.

CoAxia, Inc.

Concentric Medical, Inc.

Cordis Corporation

CytRx Corporation

EBEWE Pharma

EKOS Corporation

ev3, Inc.

Ferrer International, S.A.

FibroGen, Inc.

Fraunhofer Institute

GE Global Research Genentech, Inc. GlaxoSmithKline

Guerbet Group IRIS (Servier)

Legend Merchant Group H.

Lundbeck A/S

Medtronic, Inc.

Micrus Endovascular

MindFrame, Inc.

Mitsubishi Pharma America

Mitsubishi Pharma Europe

Mitsubishi Tanabe Pharma Neurobiological Technologies, Inc. Neurosonix, Ltd.

Neurotech Pharmaceutical Co., Ltd. Northstar Neuroscience

Novo Nordisk A/S

Nuvelo, Inc.

PAION Deutschland GmbH Penumbra, Inc. Perceptive Informatics

PhotoThera, Inc.

Sygnis Bioscience GmbH

W. L. Gore & Associates, Inc.

Wyeth Research

Xigen S.A. 

The information contained in this website reflects opinions of STAIR participants regarding the process of conducting research and development into existing, new and prospective drugs and devices for the treatment of stroke. The information is not intended to be a substitute for rigorous independent testing and development of individual compounds and devices by research sponsors, nor should the information and opinions be construed as official government regulations or official interpretations of government regulations. All government regulations and their applications to specific research studies and clinical trials are subject to individual deliberations between study sponsors and government agencies. The information contained in this website is not intended to be a substitute for sound medical advice, clinical judgment or informed treatment decisions.

STAIR® is a Registered Trademark of The Stroke Group.   

© 2020 The Stroke Group